Leapfrog Bio Announces Publication in Nature PJ Precision Oncology Validating its Proprietary Precision PGx Platform™
05 sept. 2024 07h00 HE
|
Leapfrog Bio
Leapfrog Bio today announced a publication in Nature PJ Precision Oncology describing and validating its Precision PGx Platform™
ITM Raises €188m to Enhance Radiopharmaceutical Pipeline and to Strengthen Leading Position in Medical Radioisotope Manufacturing
06 juin 2024 05h00 HE
|
ITM Isotope Technologies Munich SE
Proceeds to support development of ITM’s targeted radiopharmaceutical pipeline and preparations for potential market launch of phase III lead candidate, ITM-11, as it nears clinical read-out Funds...
Global Oncolytic Virotherapy Market Research 2024: Industry Size, Share, Trends, Opportunity & Forecasts, 2019-2029 - Focus on Personalized Medicine, Clinical Advancements Spurs Growth
14 mai 2024 10h24 HE
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Oncolytic Virotherapy Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F" report has been added to ...
$163 Billion Precision Oncology Markets - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2023 & 2024-2029F
14 mai 2024 02h52 HE
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Precision Oncology Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F" report has been added to ...
Metagenomics Market Size, Share & Trends Analysis Report 2024-2030: Emergence of New Fields in Genomics that Complement Metagenomics Fueling Expansion
13 mai 2024 10h02 HE
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Metagenomics Market Size, Share & Trends Analysis Report By Technology (Shotgun Sequencing, Whole Genome Sequencing), By Product, By Workflow, By...
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
17 avr. 2024 08h00 HE
|
Genetic Technologies Ltd
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
09 avr. 2024 16h35 HE
|
Prelude Therapeutics, Inc.
Highly selective oral SMARCA2 degrader, PRT7732, shows robust anti-tumor activity in vivo as monotherapy and in combination with chemotherapy, at well-tolerated doses Potentially best-in-class CDK9...
Global Orphan Drug Sector Poised for Growth Amidst Unmet Rare Disease Needs
05 avr. 2024 04h04 HE
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Global Orphan Drug Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This study provides critical insights into the...
Innovation Waves in Immuno-oncology Therapy Development - Next-gen Cell Therapies and Precision Immunotherapies are Driving Growth and New Product Development
21 mars 2024 05h13 HE
|
Research and Markets
Dublin, March 21, 2024 (GLOBE NEWSWIRE) -- The "Innovation Waves in Immuno-oncology Therapy Development" report has been added to ResearchAndMarkets.com's offering. Immuno-oncology (I-O)...
Omics Lab Services Market Forecast Report 2024-2029: 15% CAGR Forecast During 2024-2029, with Notable Developments in Cancer Research and Genomics
15 mars 2024 05h09 HE
|
Research and Markets
Dublin, March 15, 2024 (GLOBE NEWSWIRE) -- The "Omics Lab Services Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The omics lab services market was...